BUZZ-PegBio jumps most in 7 months on deal with Shanghai Tenry** China-based PegBio Co 2565.HK shares jump as much as 20.3% to HK$65.15, set for biggest one-day pct rise since August 15, 2025
** Innovative therapies developer's stock hit the highest point since March 9
** PegBio said it has entered into an exclusive commercialization collaboration with Shanghai Tenry Pharmaceutical for the company's core product Paidakang for treatment of type 2 diabetes in China
** Tenry Pharmaceutical will pay royalty totaling HK$140 million ($17.87 million) to the company - Co
** YTD, stock down 17.6%, while Hang Seng Biotech Index .HSBIO climbs 3.8%
($1 = 7.8322 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.